Stago offers a comprehensive range for anticoagulant monitoring. STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH, fondaparinux, apixaban, rivaroxaban, edoxaban testing.
It is based on the inhibition of a known amount of factor Xa by the patient's sample heparin/DOAC. The residual factor Xa activity assessed by a colorimetric test will be inversely proportional to the heparin/DOAC concentration.
STA®-Liquid Anti-Xamain features are summarised in the table below:
Features
Advantages
Benefits
Liquid format:
4 & 8 mL
· Ready-to-use: no reconstitution steps
· Reduced handling time: always available
· No waste of reagent: budget is optimized.
Working range:
UFH: 0.1 to 1.1 IU/mL
LMWH: 0.1 to 2.0 IU Anti-Xa/mL
FDX: 0.1 to 2.0 µg/mL
· No re-dilutions
· Allows to detect accumulation
· User-friendly & secure: no analytical mistake
Calibration:
Dedicated and hybrid calibrations
· "The choice is yours"
· Ease stock management: only 1 reference.
· Total flexibility
· Cost effective
QC levels:
UFH: 0.2 & 0.7 IU/mL
LMWH: 0.8 & 1.4 IU Anti-Xa /mL
· QC for each dose peak: represent the extreme situation
· Secure: follow-up of system performances at the limit of therapeutic ranges
Fondaparinux, apixaban, rivaroxaban, edoxaban: Dedicated Calibration and QC kits
Comply with recommendations (manufacturer, literature)
· User friendly & secure: eliminate risks of error
Safe and secure payments using Abraa safe trade systems 
\
